FERRI, NICOLA
FERRI, NICOLA
Dipartimento di Medicina - DIMED
Association between atrial fibrillation and systemic inflammation with muscle mass and strength trajectories in old age
2026 Celik, D.; Ornago, A. M.; Triolo, F.; Picca, A.; Calvani, R.; Okoye, C.; L'Angiocola, P. D.; Calderón-Larrañaga, A.; Lip, G. Y. H.; Ferri, N.; Vetrano, D. L.
Bempedoic acid and increased serum uric acid levels: a matter of concern?
2026 Bonanni, Luca; Biolo, Marta; Marodin, Giorgia; Portinari, Camilla; Simioni, Paolo; Ferri, Nicola
Comparing the 2025 ESC/EAS Focused Update and the 2026 ACC/AHA Dyslipidemia Guideline: Convergences, Divergences, and Practical Implications
2026 Bonanni, L.; Cutolo, A.; Ferri, N.
Hemostatic Aspects of Interactions between Anticancer Drugs and Oral Anticoagulants in Patients with Cancer-Associated Venous Thromboembolism
2026 Tufano, A.; Corsini, A.; Guida, A.; Costabile, S.; Ferri, N.; Mandala, M.
Integrating CYP2D6 and MATE1 activities in drug–drug interaction assessment: Insights from newly developed antidepressant drug ammoxetine
2026 Chen, R.; Ferri, N.
Mesenchymal Stem Cell-Derived Extracellular Vesicles in Myocardial Ischemia–Reperfusion Injury: A Comprehensive Review
2026 Bonanni, L.; Ferri, N.
Mesenchymal Stromal Cells at the Interface of Hemostasis and Immunothrombosis
2026 Bonanni, L.; Ferri, N.; Simioni, P.
New frontiers in the treatment of hypercholesterolaemia: oral inhibition of PCSK9
2026 Arnaboldi, L.; Tang, Z.; Ferri, N.; Corsini, A.
Optimizing Treatment in Homozygous Familial Hypercholesterolemia: Monocentric Observational Clinical Study on Efficacy and Safety of Evinacumab and Lomitapide Combination
2026 Biolo, Marta; Lupo, Maria Giovanna; Marodin, Giorgia; Portinari, Camilla; Zambon, Alberto; Bertocco, Sandra; Previato, Lorenzo; Simioni, Paolo; Ferri, Nicola; Zambon, Sabina
PCSK9 switches partner inside the vascular wall: from LDL receptor to LRP1
2026 Crescenzio, M.; Ferri, N.
Potentially Clinically Significant Drug-Drug Interactions in Older Adults with Atrial Fibrillation and Multimorbidity: Prevalence, Correlates, and Association with Adverse Clinical Outcomes in a Swedish National Register-Based Study
2026 Amrouch, Cheima; Vetrano, Davide Liborio; De Bacquer, Dirk; Ferri, Nicola; Simal, Ine; Damiano, Cecilia; Dai, Lu; Calderón-Larrañaga, Amaia; Brys, Astrid D. H.; De Spiegeleer, Anton; Lip, Gregory Y. H.; Johnsen, Søren P.; Wastesson, Jonas W.; Johnell, Kristina; De Smedt, Delphine; Petrovic, Mirko
Quality of life, care needs and priorities in atrial fibrillation: the impact of number and patterns of comorbidities
2026 Trevisan, C.; Ravelli, A.; Rivera-Caravaca, J. M.; Zanforlini, B. M.; Sergi, G.; Dan, G. -A.; Dan, A. R.; Roldan, V.; Marin Ortuno, F.; Johnsen, S. P.; Petrovic, M.; Vetrano, D. L.; Leo, D. G.; Lane, D. A.; Tokmakova, M.; Sanaullah, A.; Stockton-Powdrell, C.; Ainsworth, J.; Lea, N.; Kalra, D.; Lucci, D.; Lorimer, A.; Maggioni, A. P.; Barello, S.; Palamenghi, L.; Bosio, C.; Graffigna, G.; Marcozzi, B.; Damiano, C.; Cas, R. D.; Censi, F.; Ruppe, G.; Lobban, T.; Marczyk, J.; Cicerone, M.; Rosso, N.; Shehata, G.; Ferri, A.; Anastasia, S.; Vivani, L.; Potpara, T.; Rebba, V. S.; Buja, A.; Ferri, N.; Badila, E.; Noale, M.; Maggi, S.; Dai, L.; Calderon-Larranaga, A.; Amrouch, C.; De Buyser, S.; De Smedt, D.; Leo, D.; Collins, B.; Kypridemos, C.; Buchan, I.; Gamble, C.; O'Flaherty, M.; Lane, D.; Lip, G.; Cordsen, P.; Proietti, R.
The 2025 ESC/EAS Dyslipidaemia Focused Update: Clinical Interpretation and Practical Implications
2026 Bonanni, L.; Cutolo, A.; Ferri, N.
The role of comorbidity and frailty in shaping the burden of atrial fibrillation: a multinational cross-sectional survey
2026 Ravelli, A.; Trevisan, C.; Rivera-Caravaca, J. M.; Zanforlini, B. M.; Bosio, C.; Graffigna, G.; Sergi, G.; Dan, G. -A.; Dan, A. R.; Roldan, V.; Ortuno, F. M.; Johnsen, S. P.; Petrovic, M.; Vetrano, D. L.; Leo, D. G.; Lane, D. A.; Tokmakova, M.; Ortuno, F. M.; Sanaullah, A.; Stockton-Powdrell, C.; Ainsworth, J.; Lea, N.; Kalra, D.; Lucci, D.; Lorimer, A.; Maggioni, A. P.; Barello, S.; Palamenghi, L.; Marcozzi, B.; Damiano, C.; Da Cas, R.; Censi, F.; Ruppe, G.; Lobban, T.; Marczyk, J.; Cicerone, M.; Rosso, N.; Shehata, G.; Ferri, A.; Anastasia, S.; Vivani, L.; Potpara, T.; Trevisan, C.; Rebba, V. S.; Buja, A.; Ferri, N.; Noale, M.; Maggi, S.; Dai, L.; Calderon-Larranaga, A.; Amrouch, C.; De Buyser, S.; De Smedt, D.; Leo, D.; Collins, B.; Kypridemos, C.; Buchan, I.; Gamble, C.; O'Flaherty, M.; Lane, D.; Lip, G.; Cordsen, P.; Proietti, R.; Johnsen, S. P.
Antioxidant Activity and Potential Cholesterol Modulating Effect of Punica granatum L. Peel Hydroethanolic Extract
2025 Chaaba, R.; Nakbi, A.; Rossi, I.; Jrah, H.; Amri, Z.; Ferri, N.; Hammami, S.; Dall'Acqua, S.; Hammami, M.; Mehri, S.
Bempedoic Acid and the Uric Acid Paradox: Reflections on the Recent Meta-analysis
2025 Bonanni, Luca; Ferri, Nicola
Clinical pharmacology of combination therapies for the prevention and treatment of cardiovascular diseases
2025 Ferri, N.; Corsini, A.
Comorbidity and medication patterns in atrial fibrillation patients: association with adverse clinical outcomes
2025 Celik, Dilek; Amrouch, Cheima; Johnsen, Søren Paaske; Lip, Gregory Y H; Vetrano, Davide Liborio; Petrovic, Mirko; Zanforlini, Bruno Micael; Sergi, Giuseppe; Ferri, Nicola; Trevisan, Caterina
Do Anti-PCSK9 Monoclonal Antibodies Have Pleiotropic Effects?
2025 Ferri, N.
Drug–Drug Interactions Between DAAs and Anticoagulants or Antiplatelets: A Position Paper of the Italian Anticoagulation Clinics
2025 Tombolini, E.; Squizzato, A.; Podda, G. M.; Aghemo, A.; Ferri, N.; Segato, S.; Poli, D.; Donadini, M. P.